Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer

Journal of Pathology

Volumn 185, Issue 3, 1998, Pages 256-261

  Murray, Graeme I ^a   Duncan, Margaret E ^a   O'Neil, Pauline ^a   McKay, Judith A ^a   Melvin, William T ^a   Fothergill, John E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Collagenase; Interstitial collagenase; Matrix metalloproteinase; Neoplasm; Oesophagus

Indexed keywords

COLLAGENASE; GELATINASE A; GELATINASE B; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; COLLAGENASES; ESOPHAGEAL NEOPLASMS; FEMALE; GELATINASES; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031824909     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199807)185:3<256::AID-PATH115>3.0.CO;2-A     Document Type: Article

References (30)

1. Morson BC, Dawson IMP, Day DW, Jass JR, Price AB, Williams GT. Morson and Dawson's Gastrointestinal Pathology. 3rd edn. Oxford: Blackwell Scientific Publications, 1990; 53-70.
2. Hart IR, Saini A. Biology of tumour metastasis. Lancet 1992; 339: 1453-1457.
3. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995; 55: 1856-1862.
4. Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992; 7: 120-125.
5. Stetler-Stevenson WG, Liotta LA, Kliener DE. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993; 7: 1434-1441.
6. Davies B, Waxman J, Wasan H et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993; 53: 5365-5369.
7. Boag AH, Young ID. Increased expression of the 72-kd type IV collagenase in prostate adenocarcinoma. Am J Pathol 1994; 144: 585-591.
8. Muller D, Wolf C, Abecassis J et al. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinoma. Cancer Res 1993; 53: 165-169.
9. Urbanski SJ, Edwards DR, Hershfield N et al. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn Mol Pathol 1993; 2: 81-89.
10. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991; 5: 2145-2154.
11. Bode W. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J 1994; 13: 1263-1269.
12. Lovejoy B, Cleasby A, Hassell AM et al. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 1994; 263: 375-377.
13. Hunt LT, Barker WC, Chen HR. A domain structure common to hemopexin, vitronectin, interstitial collagenase and a collagenase homolog. Prot Seq Data Anal 1987; 1: 21-26.
14. Li J, Brick P, O'Hare MC et al Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium linked four-bladed β-propellor. Structure 1995; 3: 541-549.
15. Sato H, Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 1996; 119: 209-215.
16. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61-65.
17. Tryggvason K, Höyhtä M, Pyke M. Type IV collagenases in invasive tumors. Breast Cancer Res Treat 1993; 24: 209-218.
18. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997; 277: 225-228.
19. Hiraga A, Kemp BE, Cohen P. Further studies on the structure of the glycogen-bound form of protein phosphatase-1 from rabbit skeletal muscle. Eur J Biochem 1987; 163: 253-258.
20. Sambrook J, Fritsch EF, Muniatis T. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 1989.
21. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-497.
22. Barnes TS, Shaw PM, Burke MD, Melvin WT. Monoclonal antibodies against human cytochrome P-450 recognising different pregnenolone 16α-carbonitrile-inducible rat cytochrome P-450. Biochem J 1987; 248: 301-304.
23. Duncan ME, McAleese SM, Booth NA, Melvin WT, Fothergill JE. A simple enzyme-linked immunosorbent assay (ELISA) for the neuron-specific γ isozyme of human enolase (NSE) using monoclonal antibodies raised against synthetic peptides corresponding to isozyme sequence differences. J Immunol Methods 1992; 151: 227-236.
24. Murray GI, Duncan ME, Melvin WT, Fothergill JE. Immunohistochemistry of neuron specific enolase with gamma-subunit specific anti-peptide monoclonal antibodies. J Clin Pathol 1993; 46: 993-996.
25. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature Med 1996; 2: 461-462.
26. Shima I, Sasaguri Y, Kusukawa J et al. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behaviour of esophageal carcinoma. Cancer 1992; 70: 2747-2753.
27. Watson SA, Morris TM, Robinson G, Crimmin MJ, Brown PD, Hardcastle JD. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res 1995; 55: 3629-3633.
28. Sledge GW, Qulali M, Goulet R, Bone EA, Fife R. Effects of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 1995; 87: 1546-1550.
29. Brown PD, Giavazzi R. Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann Oncol 1995; 6: 967-974.
30. Nichifor M, Schact EH, Seymour LW. Macromolecular prodrugs of 5 fluorouracil. 2: Enzymatic degradation. J Cont Release 1996; 39: 79-92.